Friday, November 17, 2017 9:17:52 AM
Alternative Names: MCT 275
Latest Information Update: 04 Nov 2017
At a glance
Originator MultiCell Technologies Inc
Class
Mechanism of Action Immunosuppressants
Orphan Drug Status No
Highest Development Phases
No development reported Type 1 diabetes mellitus
Most Recent Events
04 Nov 2017 No recent reports of development identified for preclinical development in Type-1 diabetes mellitus in USA (Parenteral, Injection)
24 May 2006 Preclinical trials in Type-1-diabetes-mellitus in USA (unspecified route)
http://adisinsight.springer.com/drugs/800024474?query=all%3A%28%22multicell+technologies%22%29
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM